Patent ID: 11897943
Assignee: ADMA BIOMANUFACTURING, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 13:
14. The method of claim 13, wherein the pooled plasma contains opsonophagocytic antibody titers specific for at least 7 or more S. pneumonia serotypes selected from the group of S. pneumonia serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, wherein the opsonophagocytic antibody titers specific for the 7 or more S. pneumonia serotypes are each at least 5-fold higher than the opsonophagocytic antibody titers specific for the 7 or more S. pneumonia serotypes present in the control sample.